Direct measurement of hepatic extraction of chenodeoxycholic acid and ursodeoxycholic acid in man
- PMID: 7083780
- DOI: 10.1042/cs0630197
Direct measurement of hepatic extraction of chenodeoxycholic acid and ursodeoxycholic acid in man
Abstract
1. The hepatic extraction ratios of chenodeoxycholic acid and ursodeoxycholic acid have been measured in 12 patients without, and 20 patients with, liver disease. 2. Ten of the patients without liver disease were studied during cardiac catheterization, with a continuous infusion technique. Two of the patients without liver disease and all those with liver disease received an intravenous bolus of [14C]chenodeoxycholic acid or [14C]ursodeoxycholic acid, during transvenous liver biopsy. 3. The extraction ratio of chenodeoxycholic acid was 0.63 +/- 0.03 (mean +/- mean +/- SEM) and of ursodeoxycholic acid 0.53 +/- 0.01, in the patients without liver disease. In those with mild liver disease, extraction was slightly impaired (chenodeoxycholic acid; 0.49 +/0 0.03; ursodeoxycholic acid: 0.43 +/- 0.05), whereas in those with more severe liver disease it was greatly reduced (chenodeoxycholic acid: 0.16 +/- 0.08; ursodeoxycholic acid: 0.07 +/- 0.01). 4. The results suggest that (a) direct measurements confirm the accuracy of indirect estimates of hepatic extraction of chenodeoxycholic acid, (b) hepatic extraction of chenodeoxycholic acid is lower than that of cholic acid and glycocholic acid, but higher than that of ursodeoxycholic acid, (c) progressive impairment of the extraction ratios of these two bile acids occurs as the severity of liver disease increases, and (d) the ratios are correlated with indocyanine green extraction ratios.
Similar articles
-
Ursodeoxycholic acid, 7-ketolithocholic acid, and chenodeoxycholic acid are primary bile acids of the nutria (Myocastor coypus).Gastroenterology. 1986 Mar;90(3):702-9. doi: 10.1016/0016-5085(86)91126-1. Gastroenterology. 1986. PMID: 3943698
-
Direct measurement of hepatic extraction of bile acids in subjects with and without liver disease.Clin Sci (Lond). 1981 Jan;60(1):65-72. doi: 10.1042/cs0600065. Clin Sci (Lond). 1981. PMID: 7237926 Clinical Trial.
-
Comparative studies of metabolism of simultaneously administered chenodeoxycholic acid and ursodeoxycholic acid in hamsters.Steroids. 1994 Jul;59(7):431-5. doi: 10.1016/0039-128x(94)90012-4. Steroids. 1994. PMID: 7974527
-
Clinical pharmacokinetics of therapeutic bile acids.Clin Pharmacokinet. 1996 May;30(5):333-58. doi: 10.2165/00003088-199630050-00002. Clin Pharmacokinet. 1996. PMID: 8743334 Review.
-
[Enterohepatic circulation of bile acids].Nihon Rinsho. 1984 Jul;42(7):1509-14. Nihon Rinsho. 1984. PMID: 6387214 Review. Japanese. No abstract available.
Cited by
-
Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.J Lipid Res. 2014 Aug;55(8):1553-95. doi: 10.1194/jlr.R049437. Epub 2014 May 17. J Lipid Res. 2014. PMID: 24838141 Free PMC article. Review.
-
Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.Drugs. 1984 Feb;27(2):95-131. doi: 10.2165/00003495-198427020-00001. Drugs. 1984. PMID: 6365507 Review.
-
Serum bile acids and oral ursodeoxycholic acid tolerance test in the diagnosis of esophageal varices.Gastroenterol Jpn. 1987 Oct;22(5):614-20. doi: 10.1007/BF02776722. Gastroenterol Jpn. 1987. PMID: 3678732
-
Model-based data analysis of individual human postprandial plasma bile acid responses indicates a major role for the gallbladder and intestine.Physiol Rep. 2020 Mar;8(5):e14358. doi: 10.14814/phy2.14358. Physiol Rep. 2020. PMID: 32170845 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources